Safety and Efficacy of Post-Dilation in Percutaneous Coronary Intervention Using Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stentsopen access
- Authors
- Shin, Yonghoon; Won, Yoonsun; Yang, Taeil; Kim, Joohan; Lee, Joonpyo; Seo, Jeongduk; Jang, Albert Youngwoo; Kim, Minsu; Oh, Pyung Chun; Lee, Kyounghoon; Kang, Woong Chol; Han, Seung Hwan; Suh, Soon Yong
- Issue Date
- Sep-2023
- Publisher
- MDPI
- Keywords
- percutaneous coronary intervention; post-dilation; polymer-free ultrathin strut sirolimus- and probucol-eluting stents
- Citation
- MEDICINA-LITHUANIA, v.59, no.9
- Journal Title
- MEDICINA-LITHUANIA
- Volume
- 59
- Number
- 9
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/89343
- DOI
- 10.3390/medicina59091649
- ISSN
- 1010-660X
- Abstract
- Background and Objectives: Polymer-free ultrathin strut sirolimus- and probucol-eluting stents (PF-SES) are recognized as safe and effective in diverse patient populations, although the implications of post-dilation during stent implantation remain underexamined. Materials and Methods: In this study, patients implanted with PF-SES at Gachon University Gil Medical Center between December 2014 and February 2018 were evaluated. Major adverse cardiovascular events (MACE), encompassing nonfatal myocardial infarction (MI), nonfatal stroke, and cardiovascular death were identified as primary outcomes, with secondary outcomes including target vessel revascularization (TVR), target lesion revascularization (TLR), and in-stent restenosis (ISR). Results: Of the 384 initial patients, 299 were considered eligible for analysis. The groups, delineated by those undergoing post-dilation (143 patients) and those not (156 patients), exhibited comparable rates of primary outcomes [hazard ratio (HR), 2.17; 95% confidence interval (CI), 0.40 to 11.87; p = 0.37]. The outcomes remained consistent irrespective of the post-dilation status and were similarly unaffected in multivariate analyses (HR, 2.90; 95% CI, 0.52 to 16.34; p = 0.227). Conclusions: These results suggest that the clinical outcomes of patients with post-dilation were similar to that of those without post-dilation in those with the polymer-free sirolimus- and probucol-eluting stents.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/89343)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.